Drug Shortage Report for APO-CABERGOLINE
| Report ID | 41136 |
| Drug Identification Number | 02455897 |
| Brand name | APO-CABERGOLINE |
| Common or Proper name | CABERGOLINE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CABERGOLINE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 8 BTL |
| ATC code | G02CB |
| ATC description | OTHER GYNECOLOGICALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-02-26 |
| Estimated end date | Unknown |
| Actual end date | 2021-03-01 |
| Shortage status | Resolved |
| Updated date | 2021-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v25 | 2021-03-02 | English | Compare |
| v24 | 2021-03-01 | French | Compare |
| v23 | 2021-03-01 | English | Compare |
| v22 | 2020-03-30 | French | Compare |
| v21 | 2020-03-30 | English | Compare |
| v20 | 2020-02-18 | French | Compare |
| v19 | 2020-02-18 | English | Compare |
| v18 | 2019-10-07 | French | Compare |
| v17 | 2019-10-07 | English | Compare |
| v16 | 2019-09-09 | French | Compare |
| v15 | 2019-09-09 | English | Compare |
| v14 | 2019-07-12 | French | Compare |
| v13 | 2019-07-12 | English | Compare |
| v12 | 2019-04-29 | French | Compare |
| v11 | 2019-04-29 | English | Compare |
| v10 | 2019-04-22 | French | Compare |
| v9 | 2019-04-22 | English | Compare |
| v8 | 2019-03-15 | French | Compare |
| v7 | 2019-03-15 | English | Compare |
| v6 | 2018-11-30 | French | Compare |